MedTrace Logo

BioMimics 3D Stent Clinical Investigation: The Mimics Study

NCT02163863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2019-11-14

No results posted yet for this study

Summary

Primary purpose of the Mimics Study is to evaluate the safety and performance of the BioMimics 3D Stent System in the treatment of symptomatic SFA/proximal popliteal disease.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Femoropopliteal stenting

Sponsors & Collaborators

  • Veryan Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Thomas Zeller, M.D. · Universitäts-Herzzentrum Freiburg Bad Krozingen

  • Sebastian Sixt, MD · Medizinisches Versorgungszentrum Hamburg

  • Henrik Schroeder, MD · Zentrum für Minimal Invasive Therapie Berlin

  • Horst Sievert, MD · Cardiovascular Center Frankfurt

  • Karl-Ludwig Schulte, MD · Königin Elisabeth Herzberge Berlin

  • Gunnar Tepe, MD · Klinikum Rosenheim

  • Giovanni Torsello, MD · St. Franziskus Hospital Münster

  • Dierk Scheinert, MD · Park-Krankenhaus Leipzig

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2012-10-31
Completion
2014-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02163863 on ClinicalTrials.gov